October 31, 2017 05:38 PM EDT
Pharma

Greek health min­is­ter takes is­sue with Roche's with­draw­al of can­cer med­i­cine due to manda­to­ry, retroac­tive dis­count

Zachary Brennan

Senior Editor

Drug prices are not just a US prob­lem. Greece’s min­is­ter of health on Tues­day ex­pressed dis­may over Roche’s de­ci­sion to with­draw a can­cer med­i­cine be­cause …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

Pfiz­er part­ners with two more Flag­ship biotechs on obe­si­ty, can­cer

When gen­er­a­tive AI meets the FDA: First dig­i­tal health ad­comm kicks off dis­cus­sion

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times